Genomic Testing Cooperative
GTC offers advanced genomic profiling of DNA/RNA for both solid and hematologic cancers to communities everywhere. We have a turn-around time of 5-10 days and a QNS rate of <1%.
Our cooperative model allows us to partner with laboratories, hospitals, oncology practices and medical professionals to share resources which create efficiencies in cost, turnaround time and quality. GTC’s testing is NY state approved and covered by Medicare and most insurances.
Our RNA sequencing capabilities go beyond just the detection of fusions and include alternative splicing, gene expression and prediction.
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
Yes